Identifíquese
¿Aún no es suscriptor de la revista?
Comprar el acceso al artículo
Comprando el artículo el pdf del mismo podrá ser descargado
Teléfono para incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Bibliografía
[1]
Cohen S..
Motor disorders of the esophagus..
New Engl J Med, (1979), 301 pp. 184-92
[2]
Spechler SJ, Castell DO..
Classification of oesophageal motility abnormalities..
Gut, (2001), 49 pp. 145-51
[3]
Feldman M..
Southwester Internal Medicine Conference: Esophageal achalasia syndromes..
Am J Med Sci, (1988), 295 pp. 60-81
[4]
Makhlouf GM..
Smooth muscle of the gut. En: Yamada T, editor. Textbook of gastroenterology. Philadelphia: J.B. Lippincott.
Smooth muscle of the gut. En: Yamada T, editor. Textbook of gastroenterology. Philadelphia: J.B. Lippincott, (1991), pp. 61-84
[6]
De la Concha EG, Fernández-Arquero M, Mendoza JL, Conejero L, Figueredo MA, Pérez de la Serna J, et al..
Contribution of HLA class II genes to susceptibility in achalasia..
Tissue Antigens, (1998), 52 pp. 381-4
[7]
Barreca M, Oelschlager Bk, Pellegrini Ca..
Minimally invasive surgery for the treatment of achalasia..
Endoscopia, (2002), 14 pp. 59-66
[8]
Ruiz de León A, Sevilla-Mantilla C, Pérez de la Serna J..
Enfermedades Motoras del Esófago. Trastornos motores esofágicos primarios. En: Díaz-Rubio M, editor. Trastornos motores del aparato digestivo. Madrid: Ed. Médica Panamericana.
Enfermedades Motoras del Esófago. Trastornos motores esofágicos primarios. En: Díaz-Rubio M, editor. Trastornos motores del aparato digestivo. Madrid: Ed. Médica Panamericana, (1996), pp. 69-80
[9]
A. Trastornos funcionales esofágicos. Prog. Multimedia Formación Médica Continuada en Patología Digestiva. Madrid: Ed. DOYMA (CD ROM ); 2000.
[10]
Tucker HJ, Snape WJJr, Cohen S..
Achalasia secondary to carcinoma: manometric and clinical features..
Ann Intern Med, (1978), 89 pp. 315-8
[11]
Hep A, Dolina J, Dite P, Plottova Z, Valek V, Kala Z, et al..
Restoration of propulsive peristalsis of the esophagus in achalasia..
Hepatogastroenterology, (2000), 47 pp. 1203-4
[12]
Salis GB, Chiocca JC..
Puesta al día. Acalasia del esófago: Dilatación neumática..
Endoscopia, (2002), 14 pp. 89-97
[13]
Dilatación neumática del cardias en la acalasia. En: Tamames Escobar S, Martínez Ramos C, editores. Avances, controversias y actualizaciones. Cirugía General y del Aparato Digestivo II. Madrid: Ed. EMISA, 1994: p. 53-62.
[14]
Metman EH, Lagasse JP, d´Alteroche L, Picon L, Scotto B, Barbieux Jp..
Risk factors for immediate complications after progressive pneumatic dilation for achalasia..
Am J Gastroenterol, (1999), 94 pp. 1179-85
[15]
Pasricha PJ, Ravich WJ, Hendrix TR, Sostre S, Jones B, Kalloo AN..
Intrasphincteric botulinum toxin for the treatment of achalasia..
N Engl J Med, (1995), 332 pp. 774-8
[16]
Andrews CN, Anvari M, Dobranowski J..
Laparoscopic Heller's myotomy or botulinum toxin injection for management of esophageal achalasia Patient choice and treatment outcomes..
Surg Endosc, (1999), 13 pp. 742-6
[17]
Ghoshal UC, Aggarwal R, Kumar S, Naik SR..
Pneumatic dilation versus intrasphincteric botulinum toxin injection in the treatment of achalasia cardia in India: an economic analysis..
Indian J Gastroenterol, (2002), 21 pp. 193-6
[18]
O'Connor JB, Singer ME, Imperiale TF, Vaezi MF, Richter JE..
The cost-effectiveness of treatment strategies for achalasia..
Dig Dis Sci, (2002), 47 pp. 1516-25
[19]
Miller DL, Allen MS, Trastek VF, Deschamps C, Pairolero PC..
Esophageal resection for recurrent achalasia Ann Thorac Surg, (1995), pp. 60-922
[20]
Konturek J W, Gillessen A, Domschke W..
Diffuse esophageal spasm: A Malfunction That Involves Nitric Oxide?.
Scand J Gastroenterol, (1995), 30 pp. 1041-5
[21]
Richter JE Oesophageal motility disorders..
Lancet, (2001), 358 pp. 823-28
[22]
Clouse RE, Lustman PJ, Eckert TC, Ferney DM, Griffith LS..
Low-dose trazodone for symptomatic patients with esophageal contraction abnormalities. A double-blind, placebo-controlled trial..
Gastroenterology, (1987), 92 pp. 1027-36
[23]
Rey E, Alba C, Álvarez-Sánchez A, Cruz-Santamaría DM, Díaz-Rubio M..
Functional chest pain: is isobaric esophageal distension useful?.
Gastroenterology, (2002), 122 pp. A361
[24]
Handa M, Mine K, Yamamoto H, Hayashi H, Tsuchida O, Kanazawa F, et al..
Antidepressant treatment of patients with diffuse esophageal spasm: a psychosomatic approach..
J Clin Gastroenterol, (1999), 28 pp. 228-32
[26]
Miller LS, Pullela SV, Parkman HP, Schiano TD, Cassidy MJ, Cohen S, et al..
Treatment of chest pain in patients with noncardiac, nonreflux, nonachalasia spastic esophageal motor disorders using botulinum toxin injection into the gastroesophageal..
Am J Gastroenterol, (2002), 97 pp. 1640-6
[27]
Fouad-Y.M, Katz PO, Hatlebakk JG, Castell DO..
Am J Gastroenterol, (1999), 94 pp. 1464-7
[28]
Esophageal dysfunction in scleroderma: relationship with disease subsets. Arthritis Rheum1997;40:2252-59.
[29]
Lock G, Holstege A, Lang B, Scholmerich J..
Gastrointestinal manifestations of progressive systemic sclerosis..
Am J Gastroenterol, (1997), 92 pp. 763-71
